Enrollment Complete in Lipogems ARISE II Study
The ARISE I and II studies are designed to support Lipogems in obtaining a separate indication specifically for knee OA....
Mar 05, 2025,
Enrollment Complete in Lipogems ARISE II Study
Orthopedic Executives Reflect on Transformational 2024
Selected comments from the leaders of top orthopedic companies as they reported fourth quarter 2024 earnings....
Mar 05, 2025,
Biocomposites Partners to Drive Growth
Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management....
Mar 03, 2025,
Spinal Stabilization Technologies Enrolls First U.S. Patient in PerQdisc Trial
The IDE trial will assess PerQdisc's ability to replace the nucleus pulposus of a single lumbar disc to preserve motion...
Mar 03, 2025,
Enovis Completes Transformational Year; Hits $1 Billion in Recon
The company grew in the high single digits in 2024 as it made significant progress integrating its Lima acquisition....
Feb 28, 2025,
ATEC Positioned for Another Big Leap in 2025
The company grew nearly 27% in 2024 as its technology and procedural approach continued to compel surgeon adoption in the...
Feb 28, 2025,
Auxein Launches New Sports Medicine Products
The newly introduced products include the MENI-FIX 20° Curved Needle and the AUXILOCK GFS Ultimate Mini Button....
Feb 28, 2025,
Orthofix Medical to Focus on Most Profitable Opportunities
The company grew in the high single digits in 2024 and made moves to prioritize its most profitable growth opportunities...
Feb 27, 2025,
Demetra Acquires Majority Stake in GetSet Surgical
GetSet provides sterile packaged single-use surgical kits, including the GoPLF! Posterior Lateral and GoLIF! Lumbar Interbody Fusion systems....
Feb 27, 2025,
Smith+Nephew Improves, Faces Mounting Headwinds in China
The company's 12-Point Plan is producing results, but China will remain a major drag on sales and profitability in 2025....
Feb 27, 2025,
Loading new posts...
No more posts
